发明名称 |
Pyrimidinylpiperidinyloxypyridone analogues as GPR119 modulators |
摘要 |
Novel compounds of structure Formula I: (I) or an enantiomer, a diastereomer, or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein, are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the GPR119 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds.; |
申请公布号 |
US9174965(B2) |
申请公布日期 |
2015.11.03 |
申请号 |
US201314400758 |
申请日期 |
2013.05.13 |
申请人 |
Bristol-Myers Squibb Company |
发明人 |
Broekema Matthias;Wu Gang;Wacker Dean A. |
分类号 |
C07D401/14;A61K31/506;A61K31/403 |
主分类号 |
C07D401/14 |
代理机构 |
|
代理人 |
Jacobsen Barry H. |
主权项 |
1. A compound of formula I enantiomer, diastereomer, tautomer, or salt thereof wherein: R1 is hydrogen or halo; R2 is (C1-C10)alkyl; and R3 is halo or (C1-C10)alkyl. |
地址 |
Princeton NJ US |